RTKs, including EGFR (epidermal growth factor receptor), PDGFRβ (platelet-derived growth factor receptor β), and FGFR (fibroblast growth factor receptor), are key therapeutic targets of glioma [11, 23, 24]. Here, PDGFRB is linked to glioma.